OPTMED - Key Persons
Job Titles:
- Chief Operating Officer
- CTO
- FOUNDER
Mr. Klapholz has served as our Chief Operating Officer since 2013 and was appointed to serve as our Chief Financial Officer on January 14, 2022. He is also the COO of TissueMill Technologies, LLC. Over the past 26 years, Mr. Klapholz has served as a senior executive at a number of medical device companies, where he has contributed to product development, business development, and financing. He has successfully led several products through the FDA approval process. Mr. Klapholz received his B.A. in economics fromYeshiva University in 1977 and his M.B.A. in finance from the New YorkUniversity - Leonard N. Stern School of Business in 1979.
Job Titles:
- Director
- Member of Our Board of Directors
Dr. Curtis L. Cetrulo has served as a member of our board of directors since May 2022. Dr. Cetrulo has served in various roles at Massachusetts General Hospital since 2009. He has been on the faculty at Harvard Medical School ("HMS") since 2009 and is currently an Associate Professor of Surgery at HMS, and he has served as the Senior Investigator of the Vascularized Composite Tissue Allotransplantation Lab in the Center for Transplantation a Sciences at Massachusetts General Hospital, a laboratory which Dr. Cetrulo established, since 2012.
Dr. Ervin Braun has served as our Chief ExecutiveOfficer and as one of our directors since October 2012. Dr. Braun has also served as a Co-Founder and Managing Partner of Ceres Group Holdings, LLC since 2017 and serves on the board of directors of Ceres Acquisition Corp. As a serial entrepreneur for over 30 years, Dr. Braun has developed a broad portfolio of investments, including investments through financial markets, angel investing, private equity, and real estate. He has also served as a consultant for several entertainment and social media companies, as well as advised on the development of Pencils of Promise, a highly visible and successful nonprofit organization.
Job Titles:
- Member of the Medical Advisory Board
- DOCTOR
- Professor of Surgery at Stanford University
Dr. Geoffrey C. Gurtner is a Professor of Surgery at Stanford University within the division of Plastic Surgery. He is a magna cum laude graduate of Dartmouth College and an AOA graduate of the University of California-San Francisco School of Medicine.
Job Titles:
- DIRECTOR
- Member of Our Board of Directors
Dr. James J. Chao has served as a member of our board of directors since May 2022. Dr. Chao has also served as the Chief Executive Officer of Oasis MD Lifestyle Healthcare since 2012 and as the Chief Medical Officer of Prime Plastic Surgery since 2020. Prior to serving In these roles, in 2015, Dr. Chao founded ShareMD, the first medical office co-sharing system, where he and the co-founders amalgamated seven different companies and established strategic partnerships into a vertically integrated healthcare system. He also served as Clinical Professor of Surgery at the University of California San Diego for over ten years.
Job Titles:
- Member of the Medical Advisory Board
- DOCTOR
- Professor of Surgery at Stanford University
Dr. Quinn is a Professor of Surgery at Stanford University and serves as the Research Director for the Division of Emergency Medicine and as an investigator on numerous NIH-funded projects.
Job Titles:
- Director
- Member of Our Board of Directors
Dr. Kenneth Burhop has served as a member of our board of directors since May 2022. Since October 2021, Dr. Burhop has served as an advisor and consultant to various lifesciences and medical device companies. From March 2014 until October 2021, Dr. Burhop served as the Corporate Vice President, Chief Scientific Officer of Integra Lifesciences Holdings Corporation where he was responsible for setting Integra's strategic scientific vision and roadmap, as well as leading Integra's portfolio prioritization and management and the scientific evaluation of corporate development and new product opportunities.
Job Titles:
- Member of the Medical Advisory Board
- DOCTOR
- Partner at Long Island Plastic Surgical Group
Dr. Thomas Davenport has been a partner at Long Island Plastic Surgical Group since 2006. He received his MD degree from Yale University. He completed both his residency in General Surgery and fellowship in Plastic Surgery in the Harvard University Program at the Massachusetts General Hospital.
Former executive with 30+ years of experience successfully developing and implementing strategic and tactical clinical, scientific, and commercial plans to launch and grow transformative medical devices. Mr. Burrows has amassed a proven track record of developing and launching disruptive products in the acute and chronic wound healing arena. He has successfully led multi-departmental teams in medical device and pharmaceutical companies, from Johnson & Johnson®, Gore®, and Smith+Nephew®, to smaller companies like MiMedx®, CryoLife®, Histogen®, and Advanced Tissue Sciences®.
Job Titles:
- CO - CHAIRMAN
- Member of the Board of Directors
- Co - Chairman and Co - Chief Executive Officer of Sands Brothers Asset Management
Martin Sands has served as a member of the board of directors of OptMed since 2011. Since 1998, Martin has served as Co-Chairman and Co-Chief Executive Officer of Sands Brothers Asset Management, a multidisciplinary investment firm that operated venture capital, private equity, fund of funds, and hedge funds. In 2007, Martin co-founded Genesis Merchant Partners which offers strategic and opportunistic asset-based investments and secured loans in underserved markets. Martin is currently on the board of Frozen Foods Partners and Sandpoint Energy.
Job Titles:
- Director
- Chairman of the Board of Directors of CK Rehab & Pain Clinic
- Member of Our Board of Directors
Ruiping Dong has served as a member of our board of directors since July 2020. Dr. Dong also serves as the Chairman of the board of directors of CK Rehab & Pain Clinic. He is currently the Chairman of the board of directors of Jiangsu Synecoun Medical Technology Co., Ltd. ("Synecoun"). He also serves as the Chief Executive Officer of Haihe Biopharma Co, Ltd., a biopharmaceutical company that produces and sells innovative anti-tumor drugs, biomedicines, and other related products. Dr. Dong served as the Senior Vice President and Head of Emerging Markets Research and Development at Merck & Co. from 2010 to 2013.
Job Titles:
- CO - CHAIRMAN
- Director
- Co - Chairman and Co - Chief Executive Officer of Sands Brothers Asset Management
- Member of Our Board of Directors
Steven Sands has served as a member of our board of directors since 2011. Since 1998, Steven has served as Co-Chairman and Co-Chief Executive Officer of Sands Brothers Asset Management, a multi-disciplinary investment firm that operated venture capital, private equity, fund of funds, and hedge funds. In 2007, Steven co-founded Genesis Merchant Partners which offers strategic and opportunistic asset-based investments and secured loans in underserved markets. Since 2015, he has served on the board of Frozen Foods Partners.